PMC:7445716 / 9165-10279 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":481,"end":486},"obj":"Body_part"},{"id":"T16","span":{"begin":900,"end":905},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":481,"end":486},"obj":"Body_part"},{"id":"T8","span":{"begin":900,"end":905},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PD-MONDO

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T112","span":{"begin":13,"end":16},"obj":"Disease"},{"id":"T113","span":{"begin":64,"end":72},"obj":"Disease"},{"id":"T114","span":{"begin":126,"end":134},"obj":"Disease"},{"id":"T115","span":{"begin":203,"end":212},"obj":"Disease"},{"id":"T116","span":{"begin":265,"end":272},"obj":"Disease"},{"id":"T117","span":{"begin":293,"end":301},"obj":"Disease"},{"id":"T118","span":{"begin":403,"end":412},"obj":"Disease"},{"id":"T119","span":{"begin":468,"end":477},"obj":"Disease"},{"id":"T120","span":{"begin":588,"end":596},"obj":"Disease"},{"id":"T121","span":{"begin":747,"end":755},"obj":"Disease"},{"id":"T122","span":{"begin":994,"end":1002},"obj":"Disease"},{"id":"T123","span":{"begin":1016,"end":1025},"obj":"Disease"},{"id":"T124","span":{"begin":1080,"end":1088},"obj":"Disease"}],"attributes":[{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T56","span":{"begin":180,"end":182},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T57","span":{"begin":251,"end":256},"obj":"http://purl.obolibrary.org/obo/CLO_0001004"},{"id":"T58","span":{"begin":481,"end":486},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T59","span":{"begin":563,"end":565},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T60","span":{"begin":571,"end":573},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T61","span":{"begin":579,"end":581},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T62","span":{"begin":583,"end":585},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T63","span":{"begin":688,"end":693},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T64","span":{"begin":728,"end":734},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T65","span":{"begin":900,"end":905},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PubTator

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T69","span":{"begin":0,"end":95},"obj":"Sentence"},{"id":"T70","span":{"begin":96,"end":317},"obj":"Sentence"},{"id":"T71","span":{"begin":318,"end":517},"obj":"Sentence"},{"id":"T72","span":{"begin":518,"end":694},"obj":"Sentence"},{"id":"T73","span":{"begin":695,"end":767},"obj":"Sentence"},{"id":"T74","span":{"begin":768,"end":865},"obj":"Sentence"},{"id":"T75","span":{"begin":866,"end":1052},"obj":"Sentence"},{"id":"T76","span":{"begin":1053,"end":1114},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":144,"end":149},"obj":"Phenotype"},{"id":"T27","span":{"begin":166,"end":171},"obj":"Phenotype"},{"id":"T28","span":{"begin":188,"end":195},"obj":"Phenotype"},{"id":"T29","span":{"begin":203,"end":212},"obj":"Phenotype"},{"id":"T30","span":{"begin":235,"end":242},"obj":"Phenotype"},{"id":"T31","span":{"begin":265,"end":272},"obj":"Phenotype"},{"id":"T32","span":{"begin":293,"end":301},"obj":"Phenotype"},{"id":"T33","span":{"begin":371,"end":376},"obj":"Phenotype"},{"id":"T34","span":{"begin":403,"end":412},"obj":"Phenotype"},{"id":"T35","span":{"begin":468,"end":477},"obj":"Phenotype"},{"id":"T36","span":{"begin":1016,"end":1025},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0041051"},{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

LitCovid-PMC-OGER-BB

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T78","span":{"begin":64,"end":72},"obj":"SP_7"},{"id":"T79","span":{"begin":126,"end":134},"obj":"SP_7"},{"id":"T80","span":{"begin":378,"end":389},"obj":"UBERON:0001004"},{"id":"T81","span":{"begin":481,"end":486},"obj":"UBERON:0001443"},{"id":"T82","span":{"begin":588,"end":598},"obj":"SP_7"},{"id":"T83","span":{"begin":611,"end":615},"obj":"UBERON:0000004"},{"id":"T84","span":{"begin":620,"end":633},"obj":"UBERON:0001179"},{"id":"T85","span":{"begin":642,"end":647},"obj":"UBERON:0000981"},{"id":"T86","span":{"begin":747,"end":757},"obj":"SP_7"},{"id":"T87","span":{"begin":900,"end":905},"obj":"UBERON:0001443"},{"id":"T88","span":{"begin":994,"end":1002},"obj":"SP_7"},{"id":"T89","span":{"begin":1003,"end":1015},"obj":"UBERON:0005169"},{"id":"T90","span":{"begin":1080,"end":1088},"obj":"SP_7"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

2_test

{"project":"2_test","denotations":[{"id":"32840686-32588185-63205645","span":{"begin":413,"end":415},"obj":"32588185"},{"id":"32840686-32814611-63205646","span":{"begin":512,"end":514},"obj":"32814611"},{"id":"32840686-32749602-63205647","span":{"begin":562,"end":564},"obj":"32749602"},{"id":"32840686-32558002-63205648","span":{"begin":566,"end":568},"obj":"32558002"},{"id":"32840686-32753154-63205649","span":{"begin":570,"end":572},"obj":"32753154"},{"id":"32840686-32503084-63205650","span":{"begin":574,"end":576},"obj":"32503084"},{"id":"32840686-32638112-63205651","span":{"begin":578,"end":580},"obj":"32638112"},{"id":"32840686-32302082-63205652","span":{"begin":582,"end":584},"obj":"32302082"},{"id":"32840686-32761914-63205653","span":{"begin":856,"end":858},"obj":"32761914"}],"text":"All reported GBS cases (n = 72) except two were symptomatic for COVID-19 with various severity. Most common manifestations of COVID-19 included fever (73.6%, 53/72), cough (72.2%, 52/72), dyspnea and/or pneumonia (63.8%, 46/72), hypo-/ageusia (22.2%, 16/72), hypo-/anosmia (20.8%, 15/72), and diarrhea (18.1%, 13/72). One of the two asymptomatic subjects never developed fever, respiratory symptoms, or pneumonia [10], whereas the other patient showed an asymptomatic pneumonia at chest computed tomography (CT) [12]. In all but six patients with available data [22, 24, 36, 44, 45, 52], SARS-CoV-2 RT-PCR with naso- or oropharyngeal swab or fecal exam was positive at first or following tests. Nevertheless, these six patients tested positive at SARS-CoV-2 serology. In four patients, the laboratory exam for the diagnostic confirmation was not specified [20, 40]. Typical “ground glass” aspects at chest-CT or similar findings at CT, Magnetic Resonance Imaging (MRI) or X-ray compatible with COVID-19 interstitial pneumonia were reported in 40 cases. The detailed therapies for COVID-19 are described in Table 1."}

PMC:7445716 / 9165-10279 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:7445716 / 9165-10279 JSON TXT